Order Article Reprints

Ahmed AA, Otten AT, Gareb B, Huijmans JE, Eissens AC, Rehman A, Dijkstra G, Kosterink JGW, Frijlink HW, Schellekens RCA. Capsules with Ileocolonic-Targeted Release of Vitamin B₂, B₃, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process. Pharmaceutics. 2023; 15(5):1354. https://doi.org/10.3390/pharmaceutics15051354

Ahmed, Aisha A., Antonius T. Otten, Bahez Gareb, Judith E. Huijmans, Anko C. Eissens, Ateequr Rehman, Gerard Dijkstra, Jos G. W. Kosterink, Henderik W. Frijlink, and Reinout C. A. Schellekens. 2023. "Capsules with Ileocolonic-Targeted Release of Vitamin B₂, B₃, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process" Pharmaceutics 15, no. 5: 1354. https://doi.org/10.3390/pharmaceutics15051354

Ahmed, A. A., Otten, A. T., Gareb, B., Huijmans, J. E., Eissens, A. C., Rehman, A., Dijkstra, G., Kosterink, J. G. W., Frijlink, H. W., & Schellekens, R. C. A. (2023). Capsules with Ileocolonic-Targeted Release of Vitamin B₂, B₃, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process. Pharmaceutics, 15(5), 1354. https://doi.org/10.3390/pharmaceutics15051354